We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$14.5B
AUM Growth
+$172M
Cap. Flow
-$486M
Cap. Flow %
-3.36%
Top 10 Hldgs %
7.86%
Holding
1,321
New
67
Increased
464
Reduced
438
Closed
108

Sector Composition

Rank Sector Weight
1 Industrials 30.14%
2 Technology 17.94%
3 Consumer Discretionary 14.58%
4 Financials 12.3%
5 Materials 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
726
Lantheus
LNTH
$6.57B
$3.12M 0.02%
214,119
+8,904
+4% +$137K
MTSC
727
DELISTED
MTS Systems Corp
MTSC
$3.11M 0.02%
59,116
CSTM icon
728
Constellium
CSTM
$3.51B
$3.11M 0.02%
302,000
+7,000
+2% +$81.4K
CULP icon
729
Culp Inc
CULP
$45.5M
$3.1M 0.02%
126,349
+191
+0.2% +$5.68K
PRLB icon
730
Protolabs
PRLB
$1.99B
$3.09M 0.02%
26,000
APYX icon
731
Apyx Medical
APYX
$127M
$3.09M 0.02%
710,000
+23,400
+3% +$86.3K
TVTY
732
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$3.06M 0.02%
86,819
+5,770
+7% +$213K
MMS icon
733
Maximus
MMS
$3.02B
$3.05M 0.02%
49,110
EGRX
734
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.05M 0.02%
40,275
-29,768
-42% -$1.87M
HWKN icon
735
Hawkins
HWKN
$2.57B
$3.05M 0.02%
172,356
FCB
736
DELISTED
FCB Financial Holdings, Inc.
FCB
$3.02M 0.02%
51,413
AXGN icon
737
Axogen
AXGN
$2.67B
$3.02M 0.02%
60,000
-8,000
-12% -$353K
OPY icon
738
Oppenheimer Holdings
OPY
$1.21B
$3M 0.02%
107,016
-4,300
-4% -$120K
INVE icon
739
Identive
INVE
$62M
$2.97M 0.02%
767,066
-3,020
-0.4% -$11.6K
TBNK
740
DELISTED
Territorial Bancorp Inc.
TBNK
$2.97M 0.02%
95,700
PDFS icon
741
PDF Solutions
PDFS
$1.77B
$2.96M 0.02%
247,000
-37,275
-13% -$445K
SSI
742
DELISTED
Stage Stores Inc
SSI
$2.95M 0.02%
1,223,589
-15,000
-1% -$41K
EXP icon
743
Eagle Materials
EXP
$5.5B
$2.94M 0.02%
28,000
EIG icon
744
Employers Holdings
EIG
$898M
$2.92M 0.02%
72,629
STNG icon
745
Scorpio Tankers
STNG
$4.29B
$2.91M 0.02%
103,402
-69,630
-40% -$1.86M
SLAB icon
746
Silicon Laboratories
SLAB
$7.33B
$2.89M 0.02%
29,000
BSTC
747
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.89M 0.02%
64,339
+107
+0.2% +$4.6K
RGNX icon
748
Regenxbio
RGNX
$527M
$2.88M 0.02%
40,214
-36,786
-48% -$1.76M
AVD icon
749
American Vanguard Corp
AVD
$62.8M
$2.87M 0.02%
125,000
+53,000
+74% +$1.17M
TRCB
750
DELISTED
Two River Bancorp
TRCB
$2.86M 0.02%
149,600
+5,000
+3% +$88.6K

Similar funds

Royce & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Royce & Associates held 1,321 positions worth $14.5B, up 1.2% from $14.3B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Royce & Associates withdrew a net $486M in Q2 2018, closing 108 positions and reducing 438 holdings. Its most notable exit was Analogic Corp, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Comscore worth $26.1M.

  • Royce & Associates's largest Q2 2018 buy was Comscore: 59,847 shares worth $26.1M.
  • Royce & Associates added most to ProAssurance in Q2 2018, an estimated $42.4M increase.
  • Royce & Associates's biggest Q2 2018 reduction was Copart, cutting an estimated $41M.
  • Royce & Associates fully exited Analogic Corp in Q2 2018, selling an estimated $49.9M.
  • Royce & Associates's ten largest holdings make up 7.9% of its $14.5B portfolio in Q2 2018.
  • Royce & Associates opened 67 new positions and closed 108 in Q2 2018.
  • Royce & Associates's portfolio value rose 1.2% quarter-over-quarter to $14.5B.

Based on Royce & Associates's 13F filing for Q2 2018, filed 9 Aug 2018.